{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T07:10:14Z","timestamp":1788765014249,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12015-026-11181-x","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:29:46Z","timestamp":1784186986000},"page":"3117-3130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human Umbilical Cord Mesenchymal Stem Cells in Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Therapy: Mechanisms, Clinical Efficacy, and Future Perspectives"],"prefix":"10.1007","volume":"22","author":[{"given":"Hua","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"4","key":"11181_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/biology13040243","volume":"13","author":"C Long","year":"2024","unstructured":"Long, C., Zhou, X., Xia, F., & Zhou, B. (2024). Intestinal barrier dysfunction and gut microbiota in non-alcoholic fatty liver disease: assessment, mechanisms, and therapeutic considerations. Biology, 13(4), 243\u2013268. https:\/\/doi.org\/10.3390\/biology13040243","journal-title":"Biology"},{"issue":"33","key":"11181_CR2","doi-asserted-by":"publisher","first-page":"e43952","DOI":"10.1097\/MD.0000000000043952","volume":"104","author":"Q Zhou","year":"2025","unstructured":"Zhou, Q., Liu, W., Zhou, D., Zhang, Y., Li, Z., Li, Z., & Ma, X. (2025). Association between metabolic dysfunction-associated steatotic liver disease and cardiovascular disease: new perspectives. Medicine, 104(33), e43952. https:\/\/doi.org\/10.1097\/MD.0000000000043952","journal-title":"Medicine"},{"issue":"19","key":"11181_CR3","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/cells13191604","volume":"13","author":"M Akabane","year":"2024","unstructured":"Akabane, M., Imaoka, Y., Kawashima, J., Endo, Y., Schenk, A., Sasaki, K., & Pawlik, T. M. (2024). Innovative strategies for liver transplantation: the role of mesenchymal stem cells and their cell-free derivatives. Cells, 13(19), 1604. https:\/\/doi.org\/10.3390\/cells13191604","journal-title":"Cells"},{"issue":"23","key":"11181_CR4","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.1039\/D0BM01221A","volume":"8","author":"W Cai","year":"2020","unstructured":"Cai, W., Sun, J., Sun, Y., Zhao, X., Guo, C., Dong, J., & Zhang, R. (2020). NIR-II FL\/PA dual-modal imaging long-term tracking of human umbilical cord-derived mesenchymal stem cells labeled with melanin nanoparticles and visible HUMSC-based liver regeneration for acute liver failure. Biomaterials Science, 8(23), 6592\u20136602. https:\/\/doi.org\/10.1039\/D0BM01221A","journal-title":"Biomaterials Science"},{"issue":"4","key":"11181_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.livres.2024.11.004","volume":"8","author":"Z Liu","year":"2024","unstructured":"Liu, Z., Ren, J., Qiu, C., Wang, Y., & Zhang, T. (2024). Application of mesenchymal stem cells in liver fibrosis and regeneration. Liver Research, 8(4), 246\u2013258. https:\/\/doi.org\/10.1016\/j.livres.2024.11.004","journal-title":"Liver Research"},{"key":"11181_CR6","doi-asserted-by":"publisher","first-page":"1123547","DOI":"10.3389\/fmicb.2023.1123547","volume":"14","author":"JH Shin","year":"2023","unstructured":"Shin, J. H., Lee, Y., Song, E. J., Lee, D., Jang, S. Y., Byeon, H. R., & Nam, Y. D. (2023). Faecalibacterium prausnitzii prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet. Frontiers in Microbiology, 14, 1123547. https:\/\/doi.org\/10.3389\/fmicb.2023.1123547","journal-title":"Frontiers in Microbiology"},{"key":"11181_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3389\/fcell.2020.00601","volume":"8","author":"C Wang","year":"2020","unstructured":"Wang, C., Li, Y., Li, H., Zhang, Y., Ying, Z., Wang, X., & Pan, X. (2020). Disruption of FGF signaling ameliorates inflammatory response in hepatic stellate cells. Frontiers in Cell and Developmental Biology, 8, 601\u2013613. https:\/\/doi.org\/10.3389\/fcell.2020.00601","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"11181_CR8","doi-asserted-by":"publisher","first-page":"1454980","DOI":"10.3389\/fmed.2024.1454980","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Ren, L., Tian, Y., Guo, X., Wei, F., & Zhang, Y. (2024). Signaling pathways that activate hepatic stellate cells during liver fibrosis. Frontiers in Medicine, 11, 1454980. https:\/\/doi.org\/10.3389\/fmed.2024.1454980","journal-title":"Frontiers in Medicine"},{"issue":"5","key":"11181_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/cells9051163","volume":"9","author":"MM Barreca","year":"2020","unstructured":"Barreca, M. M., Cancemi, P., & Geraci, F. (2020). Mesenchymal and induced pluripotent stem cells-derived extracellular vesicles: the new frontier for regenerative medicine? Cells, 9(5), 1163. https:\/\/doi.org\/10.3390\/cells9051163","journal-title":"Cells"},{"issue":"1","key":"11181_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13287-022-02754-x","volume":"13","author":"P Wang","year":"2022","unstructured":"Wang, P., Cui, Y., Wang, J., Liu, D., Tian, Y., Liu, K., & You, H. (2022). Mesenchymal stem cells protect against acetaminophen hepatotoxicity by secreting regenerative cytokine hepatocyte growth factor. Stem Cell Research & Therapy, 13(1), 94\u2013107. https:\/\/doi.org\/10.1186\/s13287-022-02754-x","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"11181_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s40001-023-01244-x","volume":"28","author":"T Lin","year":"2023","unstructured":"Lin, T., Yang, Y., & Chen, X. (2023). A review of the application of mesenchymal stem cells in the field of hematopoietic stem cell transplantation. European Journal of Medical Research, 28(1), 268\u2013280. https:\/\/doi.org\/10.1186\/s40001-023-01244-x","journal-title":"European Journal of Medical Research"},{"issue":"9","key":"11181_CR12","doi-asserted-by":"publisher","first-page":"110811","DOI":"10.1016\/j.isci.2024.110811","volume":"27","author":"R Lu","year":"2024","unstructured":"Lu, R., Zheng, K., Zhou, Y., Wang, W., Zhang, Y., Chen, Y., & Wu, Y. (2024). 3D spheroid culture synchronizes heterogeneous MSCs into an immunomodulatory phenotype with enhanced anti-inflammatory effects. iScience, 27(9), 110811. https:\/\/doi.org\/10.1016\/j.isci.2024.110811","journal-title":"iScience"},{"issue":"1","key":"11181_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13008-023-00104-8","volume":"19","author":"H Xu","year":"2024","unstructured":"Xu, H., Huang, Y., Zhang, F., Shi, W., Cheng, Y., Yang, K., & Liu, L. (2024). Ultrasonic microbubbles promote mesenchymal stem cell homing to the fibrotic liver via upregulation of CXCR4 expression. Cell Division, 19(1), 7\u201318. https:\/\/doi.org\/10.1186\/s13008-023-00104-8","journal-title":"Cell Division"},{"issue":"1","key":"11181_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13287-025-04197-6","volume":"16","author":"W Jiang","year":"2025","unstructured":"Jiang, W., Zeng, Q., Liu, C. H., Wang, Y., Wang, S., Chen, E., & Tang, H. (2025). Huc-MSCs-derived exosomes alleviate non-alcoholic steatohepatitis by regulating macrophages polarization through miR-24-3p\/STING axis. Stem Cell Research & Therapy, 16(1), 74\u201387. https:\/\/doi.org\/10.1186\/s13287-025-04197-6","journal-title":"Stem Cell Research & Therapy"},{"issue":"9","key":"11181_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song, N., Scholtemeijer, M., & Shah, K. (2020). Mesenchymal stem cell immunomodulation: Mechanisms and therapeutic potential. Trends in Pharmacological Sciences, 41(9), 653\u2013664. https:\/\/doi.org\/10.1016\/j.tips.2020.06.009","journal-title":"Trends in Pharmacological Sciences"},{"issue":"8","key":"11181_CR16","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1248\/bpb.b16-00777","volume":"40","author":"W Yan","year":"2017","unstructured":"Yan, W., Li, D., Chen, T., Tian, G., Zhou, P., & Ju, X. (2017). Umbilical cord MSCs reverse D-galactose-induced hepatic mitochondrial dysfunction via activation of Nrf2\/HO-1 pathway. Biological & Pharmaceutical Bulletin, 40(8), 1174\u20131182. https:\/\/doi.org\/10.1248\/bpb.b16-00777","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"1","key":"11181_CR17","doi-asserted-by":"publisher","first-page":"4639115","DOI":"10.1155\/sci\/4639115","volume":"2025","author":"R Hu","year":"2025","unstructured":"Hu, R., Zhao, J., Cheng, Y., Su, W., Ren, R., Zhang, H., & Yu, S. (2025). Exogenous mitochondrial pretreatment enhances the therapeutic effect of UC-MSCs on NAFLD in type 2 diabetic mice by mediating mitochondrial transfer. Stem Cells International, 2025(1), 4639115. https:\/\/doi.org\/10.1155\/sci\/4639115","journal-title":"Stem Cells International"},{"issue":"1","key":"11181_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s13287-025-04535-8","volume":"16","author":"V Bozorgi","year":"2025","unstructured":"Bozorgi, V., Babaahmadi, M., Salehi, M., Vafaeimanesh, J., & Hajizadeh-Saffar, E. (2025). From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy. Stem Cell Research & Therapy, 16(1), 421\u2013436. https:\/\/doi.org\/10.1186\/s13287-025-04535-8","journal-title":"Stem Cell Research & Therapy"},{"issue":"21","key":"11181_CR19","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.21037\/atm-21-2885","volume":"9","author":"M Liu","year":"2021","unstructured":"Liu, M., He, J., Zheng, S., Zhang, K., Ouyang, Y., Zhang, Y., & Wu, D. (2021). Human umbilical cord mesenchymal stem cells ameliorate acute liver failure by inhibiting apoptosis, inflammation and pyroptosis. Annals of Translational Medicine, 9(21), 1615\u20131615. https:\/\/doi.org\/10.21037\/atm-21-2885","journal-title":"Annals of Translational Medicine"},{"key":"11181_CR20","doi-asserted-by":"publisher","first-page":"1639439","DOI":"10.3389\/fbioe.2025.1639439","volume":"13","author":"JC Patel","year":"2025","unstructured":"Patel, J. C., Shukla, M., & Shukla, M. (2025). From bench to bedside: translating mesenchymal stem cell therapies through preclinical and clinical evidence. Frontiers in Bioengineering and Biotechnology, 13, 1639439. https:\/\/doi.org\/10.3389\/fbioe.2025.1639439","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"6","key":"11181_CR21","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.3390\/ijms25063478","volume":"25","author":"S Wang","year":"2024","unstructured":"Wang, S., Luo, J., Wang, H., Chen, T., Sun, J., Xi, Q., & Zhang, Y. (2024). Extracellular vesicles: A crucial player in the intestinal microenvironment and beyond. International Journal of Molecular Sciences, 25(6), 3478. https:\/\/doi.org\/10.3390\/ijms25063478","journal-title":"International Journal of Molecular Sciences"},{"key":"11181_CR22","doi-asserted-by":"publisher","first-page":"101382","DOI":"10.1016\/j.tice.2020.101382","volume":"66","author":"X Xu","year":"2020","unstructured":"Xu, X., Wang, W., Lin, L., & Chen, P. (2020). Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4\/NF-kB inflammatory pathway and oxidative stress in T2DM\/NAFLD rats. Tissue and Cell, 66, 101382. https:\/\/doi.org\/10.1016\/j.tice.2020.101382","journal-title":"Tissue and Cell"},{"issue":"5","key":"11181_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/ph17050607","volume":"17","author":"Y Qiao","year":"2024","unstructured":"Qiao, Y., Tang, X., Liu, Z., Ocansey, D. K. W., Zhou, M., Shang, A., & Mao, F. (2024). Therapeutic prospects of mesenchymal stem cell and their derived exosomes in the regulation of the gut microbiota in inflammatory bowel disease. Pharmaceuticals, 17(5), 607\u2013628. https:\/\/doi.org\/10.3390\/ph17050607","journal-title":"Pharmaceuticals"},{"key":"11181_CR24","doi-asserted-by":"publisher","first-page":"660614","DOI":"10.3389\/fmed.2021.660614","volume":"8","author":"L Gu","year":"2021","unstructured":"Gu, L., Ren, F., Fang, X., Yuan, L., Liu, G., & Wang, S. (2021). Exosomal MicroRNA-181a derived from mesenchymal stem cells improves gut microbiota composition, barrier function, and inflammatory status in an experimental colitis model. Frontiers in Medicine, 8, 660614. https:\/\/doi.org\/10.3389\/fmed.2021.660614","journal-title":"Frontiers in Medicine"},{"issue":"1","key":"11181_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.gande.2024.12.001","volume":"3","author":"J Xue","year":"2025","unstructured":"Xue, J., Hu, X., Xia, S., Ren, P., & Wang, A. (2025). Human umbilical cord derived-mesenchymal stem cells alleviate lipid metabolism disturbances of hepatocytes via mitochondrial transport. Gastroenterology & Endoscopy, 3(1), 47\u201352. https:\/\/doi.org\/10.1016\/j.gande.2024.12.001","journal-title":"Gastroenterology & Endoscopy"},{"issue":"4","key":"11181_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.iliver.2022.11.006","volume":"1","author":"C Han","year":"2022","unstructured":"Han, C., Wang, R., Xu, N., Wei, X., Wei, Q., & Xu, X. (2022). Visual analysis of mesenchymal stem cell research. in liver disease based on bibliometrics iLIVER, 1(4), 283\u2013291. https:\/\/doi.org\/10.1016\/j.iliver.2022.11.006","journal-title":"in liver disease based on bibliometrics iLIVER"},{"issue":"7","key":"11181_CR27","doi-asserted-by":"publisher","first-page":"100746","DOI":"10.1016\/j.jhepr.2023.100746","volume":"5","author":"F Yang","year":"2023","unstructured":"Yang, F., Wu, Y., Chen, Y., Xi, J., Chu, Y., Jin, J., & Yan, Y. (2023). Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis. JHEP Reports, 5(7), 100746. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100746","journal-title":"JHEP Reports"},{"issue":"1","key":"11181_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13287-022-02848-6","volume":"13","author":"L Zang","year":"2022","unstructured":"Zang, L., Li, Y., Hao, H., Liu, J., Cheng, Y., Li, B., & Mu, Y. (2022). Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: A single-center, double-blinded, randomized, placebo-controlled phase II trial. Stem Cell Research & Therapy, 13(1), 180. https:\/\/doi.org\/10.1186\/s13287-022-02848-6","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"11181_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s13770-024-00675-9","volume":"22","author":"JJ Han","year":"2025","unstructured":"Han, J. J., Li, J., & Huang, D. H. (2025). Mesenchymal stem cell-derived extracellular vesicles carrying circ-Tulp4 attenuate diabetes mellitus with nonalcoholic fatty liver disease by inhibiting cell pyroptosis through the HNRNPC\/ABHD6 axis. Tissue Engineering and Regenerative Medicine, 22(1), 23\u201341. https:\/\/doi.org\/10.1007\/s13770-024-00675-9","journal-title":"Tissue Engineering and Regenerative Medicine"},{"issue":"1","key":"11181_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12951-025-03291-4","volume":"23","author":"Z Wang","year":"2025","unstructured":"Wang, Z., Yuan, M., Yao, L., Xiong, Z., Dai, K., Liu, P., & Jiang, Y. (2025). Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1\/GPX4-mediated ferroptosis in hepatic stellate cells. Journal of Nanobiotechnology, 23(1), 222. https:\/\/doi.org\/10.1186\/s12951-025-03291-4","journal-title":"Journal of Nanobiotechnology"},{"issue":"6","key":"11181_CR31","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s13577-021-00593-1","volume":"34","author":"L Cheng","year":"2021","unstructured":"Cheng, L., Yu, P., Li, F., Jiang, X., Jiao, X., Shen, Y., & Lai, X. (2021). Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression. Human Cell, 34(6), 1697\u20131708. https:\/\/doi.org\/10.1007\/s13577-021-00593-1","journal-title":"Human Cell"},{"issue":"1","key":"11181_CR32","doi-asserted-by":"publisher","first-page":"18431","DOI":"10.1038\/s41598-023-45828-3","volume":"13","author":"C Liang","year":"2023","unstructured":"Liang, C., Gao, S., Gao, J., Xu, Y., & Li, Q. (2023). Comparison of effects of HucMSCs, exosomes, and conditioned medium on NASH. Scientific Reports, 13(1), 18431. https:\/\/doi.org\/10.1038\/s41598-023-45828-3","journal-title":"Scientific Reports"},{"issue":"1\u20132","key":"11181_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11010-017-2940-1","volume":"429","author":"J Xuan","year":"2017","unstructured":"Xuan, J., Feng, W., An, Z., Yang, J., Xu, H., Li, J., & Wen, W. (2017). Anti-TGF\u03b2-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGF\u03b2-1\/smad pathway. Molecular and Cellular Biochemistry, 429(1\u20132), 113\u2013122. https:\/\/doi.org\/10.1007\/s11010-017-2940-1","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"2","key":"11181_CR34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4093\/dmj.2019.0191","volume":"45","author":"KS Kim","year":"2021","unstructured":"Kim, K. S., Choi, Y. K., Kim, M. J., Hwang, J. W., Min, K., Jung, S. Y., & Cho, Y. W. (2021). Umbilical cord-mesenchymal stem cell-conditioned medium improves insulin resistance in C2C12 cell. Diabetes & Metabolism Journal, 45(2), 260\u2013269. https:\/\/doi.org\/10.4093\/dmj.2019.0191","journal-title":"Diabetes & Metabolism Journal"},{"issue":"1","key":"11181_CR35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13287-022-02832-0","volume":"13","author":"A Aierken","year":"2022","unstructured":"Aierken, A., Li, B., Liu, P., Cheng, X., Kou, Z., Tan, N., & Hua, J. (2022). Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K\/AKT signaling pathway. Stem Cell Research & Therapy, 13(1), 164\u2013178. https:\/\/doi.org\/10.1186\/s13287-022-02832-0","journal-title":"Stem Cell Research & Therapy"},{"issue":"13","key":"11181_CR36","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/polym16131845","volume":"16","author":"J Yang","year":"2024","unstructured":"Yang, J., Liu, Y., Wang, M., Chen, S., Miao, Q., Liu, Z., & Deng, G. (2024). Repair effect of umbilical cord mesenchymal stem cells embedded in hydrogel on mouse insulinoma 6 cells injured by streptozotocin. Polymers, 16(13), 1845. https:\/\/doi.org\/10.3390\/polym16131845","journal-title":"Polymers"},{"key":"11181_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2022.08.037","volume":"192","author":"Y Kang","year":"2022","unstructured":"Kang, Y., Song, Y., Luo, Y., Song, J., Li, C., Yang, S., & Zhang, X. (2022). Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2\/NQO-1 pathway. Free Radical Biology and Medicine, 192, 25\u201336. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.08.037","journal-title":"Free Radical Biology and Medicine"},{"issue":"1","key":"11181_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13287-022-03030-8","volume":"13","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q., Rong, C., Gu, T., Li, H., Wu, L., Zhuansun, X., & Wang, S. (2022). Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of notch signaling pathway. Stem Cell Research & Therapy, 13(1), 354\u2013370. https:\/\/doi.org\/10.1186\/s13287-022-03030-8","journal-title":"Stem Cell Research & Therapy"},{"issue":"9","key":"11181_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4252\/wjsc.v16.i9.846","volume":"16","author":"FQ Gao","year":"2024","unstructured":"Gao, F. Q., Zhu, J. Q., & Feng, X. D. (2024). Innovative mesenchymal stem cell treatments for fatty liver disease. World Journal of Stem Cells, 16(9), 846\u2013853. https:\/\/doi.org\/10.4252\/wjsc.v16.i9.846","journal-title":"World Journal of Stem Cells"},{"key":"11181_CR40","doi-asserted-by":"publisher","first-page":"1677021","DOI":"10.3389\/fmed.2025.1677021","volume":"12","author":"Y Huang","year":"2026","unstructured":"Huang, Y., Cheng, R., Wang, G., Xu, Z., Liu, S., Wan, Y., & Wang, J. (2026). Harnessing mesenchymal stromal cells for liver disease therapy: From mechanistic discoveries to clinical breakthroughs. Frontiers in Medicine, 12, 1677021. https:\/\/doi.org\/10.3389\/fmed.2025.1677021","journal-title":"Frontiers in Medicine"},{"issue":"5","key":"11181_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.61186\/ibj.4357","volume":"28","author":"S Saki","year":"2024","unstructured":"Saki, S., Monjezi, S., Ghaffari, F., Orak, G., Salehipour Bavarsad, S., Khedri, A., & Hatami, M. (2024). Unraveling the exosome-miR-133a axis: Targeting TGF-\u03b2 signaling via WJ-MSC-derived exosomes for anti-fibrotic therapy in liver fibrosis. Iranian Biomedical Journal, 28(5), 235\u2013244. https:\/\/doi.org\/10.61186\/ibj.4357","journal-title":"Iranian Biomedical Journal"},{"issue":"5\u20136","key":"11181_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1515\/znc-2021-0201","volume":"77","author":"CZ Zhao","year":"2022","unstructured":"Zhao, C. Z., Jiang, L., Li, W. Y., Wu, G., Chen, J., Dong, L. H., & Wei, R. R. (2022). Establishment and metabonomics analysis of nonalcoholic fatty liver disease model in golden hamster. Zeitschrift f\u00fcr Naturforschung C, 77(5\u20136), 197\u2013206. https:\/\/doi.org\/10.1515\/znc-2021-0201","journal-title":"Zeitschrift f\u00fcr Naturforschung C"},{"issue":"1","key":"11181_CR43","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s13287-025-04747-y","volume":"16","author":"S Yu","year":"2025","unstructured":"Yu, S., Kong, D., Lu, B., Pan, Y., Zeng, Z., Fu, Y., & Xia, Q. (2025). Mesenchymal stem cell-derived exosomes as cell-free therapeutics: mechanistic insights and engineering strategies for liver disease treatment. Stem Cell Research & Therapy, 16(1), 652\u2013673. https:\/\/doi.org\/10.1186\/s13287-025-04747-y","journal-title":"Stem Cell Research & Therapy"},{"issue":"21","key":"11181_CR44","doi-asserted-by":"publisher","first-page":"21660","DOI":"10.18632\/aging.103962","volume":"12","author":"Z Yang","year":"2020","unstructured":"Yang, Z., Xia, Q., Lu, D., Yue, H., Zhang, J., Li, Y., & Cao, M. (2020). Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis. Aging (Albany Ny), 12(21), 21660\u201321673. https:\/\/doi.org\/10.18632\/aging.103962","journal-title":"Aging (Albany Ny)"},{"issue":"1","key":"11181_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13287-021-02222-y","volume":"12","author":"M Mebarki","year":"2021","unstructured":"Mebarki, M., Abadie, C., Larghero, J., & Cras, A. (2021). Human umbilical cord-derived mesenchymal stem\/stromal cells: A promising candidate for the development of advanced therapy medicinal products. Stem Cell Research & Therapy, 12(1), 152. https:\/\/doi.org\/10.1186\/s13287-021-02222-y","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"11181_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12860-025-00539-7","volume":"26","author":"ME Williams","year":"2025","unstructured":"Williams, M. E., Banche Niclot, F., Rota, S., Lim, J., Machado, J., De Azevedo, R., & Taraballi, F. (2025). Optimizing mesenchymal stem cell therapy: from isolation to GMP-compliant expansion for clinical application. BMC Molecular and Cell Biology, 26(1), 15. https:\/\/doi.org\/10.1186\/s12860-025-00539-7","journal-title":"BMC Molecular and Cell Biology"},{"issue":"6","key":"11181_CR47","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jcyt.2023.11.003","volume":"26","author":"BH Shaz","year":"2024","unstructured":"Shaz, B. H., Sch\u00e4fer, R., Fontaine, M. J., Norris, P. J., McKenna, D. H., Jin, P., & Pati, S. (2024). Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: A biomedical excellence for safer transfusion (BEST) collaborative study. Cytotherapy, 26(6), 531\u2013539. https:\/\/doi.org\/10.1016\/j.jcyt.2023.11.003","journal-title":"Cytotherapy"},{"issue":"1","key":"11181_CR48","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1186\/s12967-024-05373-7","volume":"22","author":"B Krupczak","year":"2024","unstructured":"Krupczak, B., Farruggio, C., & Van Vliet, K. J. (2024). Manufacturing mesenchymal stromal cells in a microcarrier-microbioreactor platform can enhance cell yield and quality attributes: case study for acute respiratory distress syndrome. Journal of Translational Medicine, 22(1), 614. https:\/\/doi.org\/10.1186\/s12967-024-05373-7","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"11181_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.20517\/evcna.2025.55","volume":"6","author":"TT Tan","year":"2025","unstructured":"Tan, T. T., & Lim, S. K. (2025). Rethinking miRNAs in MSC-sEV therapeutics: implications for manufacture, mechanism of action, and development of robust potency CQAs. Extracellular Vesicles and Circulating Nucleic Acids, 6(4), 807\u2013821. https:\/\/doi.org\/10.20517\/evcna.2025.55","journal-title":"Extracellular Vesicles and Circulating Nucleic Acids"},{"key":"11181_CR50","doi-asserted-by":"publisher","first-page":"096368972110394","DOI":"10.1177\/09636897211039441","volume":"30","author":"MQ Nguyen","year":"2021","unstructured":"Nguyen, M. Q., Bui, H. T. H., Tuyet, A. N. T., Nhung, T. T. H., Hoang, D. M., Liem, N. T., & Hoang, V. T. (2021). Comparative bioactivity analysis for off-the-shelf and culture\u2013rescued umbilical cord-derived mesenchymal stem\/stromal cells in a xeno- and serum-free culture system. Cell Transplantation, 30, 09636897211039441. https:\/\/doi.org\/10.1177\/09636897211039441","journal-title":"Cell Transplantation"},{"key":"11181_CR51","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fbioe.2020.00586","volume":"8","author":"X Wu","year":"2020","unstructured":"Wu, X., Wu, D., Mu, Y., Zhao, Y., & Ma, Z. (2020). Serum-free medium enhances the therapeutic effects of umbilical cord mesenchymal stromal cells on a murine model for acute colitis. Frontiers in Bioengineering and Biotechnology, 8, 586. https:\/\/doi.org\/10.3389\/fbioe.2020.00586","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"3","key":"11181_CR52","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13770-021-00352-1","volume":"18","author":"JY Kim","year":"2021","unstructured":"Kim, J. Y., Rhim, W. K., Seo, H. J., Lee, J. Y., Park, C. G., & Han, D. K. (2021). Comparative analysis of MSC-derived exosomes depending on cell culture media for regenerative bioactivity. Tissue Engineering and Regenerative Medicine, 18(3), 355\u2013367. https:\/\/doi.org\/10.1007\/s13770-021-00352-1","journal-title":"Tissue Engineering and Regenerative Medicine"},{"issue":"10","key":"11181_CR53","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.jcyt.2023.07.004","volume":"25","author":"P Todtenhaupt","year":"2023","unstructured":"Todtenhaupt, P., Franken, L. A., Groene, S. G., Van Hoolwerff, M., Van Der Meeren, L. E., Van Klink, J. M. M., & Van Pel, M. (2023). A robust and standardized method to isolate and expand mesenchymal stromal cells from human umbilical cord. Cytotherapy, 25(10), 1057\u20131068. https:\/\/doi.org\/10.1016\/j.jcyt.2023.07.004","journal-title":"Cytotherapy"},{"issue":"12","key":"11181_CR54","doi-asserted-by":"publisher","first-page":"12366","DOI":"10.1021\/acsnano.5c02532","volume":"19","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y., Song, J., Wang, B., Wen, Y., Jiang, W., Zhang, Y. L., & Liu, B. C. (2025). Comprehensive comparison of extracellular vesicles derived from mesenchymal stem cells cultured with fetal bovine serum and human platelet lysate. Acs Nano, 19(12), 12366\u201312381. https:\/\/doi.org\/10.1021\/acsnano.5c02532","journal-title":"Acs Nano"},{"issue":"7","key":"11181_CR55","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jcyt.2025.03.505","volume":"27","author":"B Giebel","year":"2025","unstructured":"Giebel, B., & Lim, S. K. (2025). Overcoming challenges in MSC-sEV therapeutics: insights and advances after a decade of research. Cytotherapy, 27(7), 843\u2013848. https:\/\/doi.org\/10.1016\/j.jcyt.2025.03.505","journal-title":"Cytotherapy"},{"issue":"4","key":"11181_CR56","doi-asserted-by":"publisher","first-page":"244","DOI":"10.62347\/OPHF7871","volume":"14","author":"R Raoufinia","year":"2025","unstructured":"Raoufinia, R. (2025). Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cell transplantation in type 2 diabetes: A pilot clinical trial. American Journal of Stem Cells, 14(4), 244\u2013260. https:\/\/doi.org\/10.62347\/OPHF7871","journal-title":"American Journal of Stem Cells"},{"issue":"18","key":"11181_CR57","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1097\/CM9.0000000000003768","volume":"138","author":"L Cui","year":"2025","unstructured":"Cui, L., Zou, H., You, S., Guo, C., Gu, J., Shang, Y., & Han, Y. (2025). Off-the-shelf human umbilical cord mesenchymal stromal cell product in acute-on-chronic liver failure: a multicenter phase I\/II clinical trial. Chinese Medical Journal, 138(18), 2347\u20132349. https:\/\/doi.org\/10.1097\/CM9.0000000000003768","journal-title":"Chinese Medical Journal"},{"issue":"6","key":"11181_CR58","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s12072-024-10717-y","volume":"18","author":"R Zong","year":"2024","unstructured":"Zong, R., Zheng, Y., Yan, Y., Sun, W., Kong, L., Huang, Y., & Li, C. (2024). Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting hedgehog\/SMO signaling. Hepatology International, 18(6), 1781\u20131791. https:\/\/doi.org\/10.1007\/s12072-024-10717-y","journal-title":"Hepatology International"},{"issue":"3","key":"11181_CR59","doi-asserted-by":"publisher","first-page":"e25460","DOI":"10.1016\/j.heliyon.2024.e25460","volume":"10","author":"J Hu","year":"2024","unstructured":"Hu, J., Li, S., Zhong, X., Wei, Y., Sun, Q., & Zhong, L. (2024). Human umbilical cord mesenchymal stem cells attenuate diet-induced obesity and NASH-related fibrosis in mice. Heliyon, 10(3), e25460. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25460","journal-title":"Heliyon"},{"issue":"12","key":"11181_CR60","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.jcyt.2017.08.004","volume":"19","author":"A Can","year":"2017","unstructured":"Can, A., Celikkan, F. T., & Cinar, O. (2017). Umbilical cord mesenchymal stromal cell transplantations: a systemic analysis of clinical trials. Cytotherapy, 19(12), 1351\u20131382. https:\/\/doi.org\/10.1016\/j.jcyt.2017.08.004","journal-title":"Cytotherapy"},{"issue":"6","key":"11181_CR61","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1016\/j.ymthe.2025.02.003","volume":"33","author":"W Lu","year":"2025","unstructured":"Lu, W., & Allickson, J. (2025). Mesenchymal stromal cell therapy: progress to date and future outlook. Molecular Therapy, 33(6), 2679\u20132688. https:\/\/doi.org\/10.1016\/j.ymthe.2025.02.003","journal-title":"Molecular Therapy"},{"issue":"24","key":"11181_CR62","doi-asserted-by":"publisher","first-page":"13562","DOI":"10.3390\/ijms252413562","volume":"25","author":"N Yamaguchi","year":"2024","unstructured":"Yamaguchi, N., Horio, E., Sonoda, J., Yamagishi, M., Miyakawa, S., Murakami, F., & Yoshimoto, T. (2024). Immortalization of mesenchymal stem cells for application in regenerative medicine and their potential risks of tumorigenesis. International Journal of Molecular Sciences, 25(24), 13562. https:\/\/doi.org\/10.3390\/ijms252413562","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"11181_CR63","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1089\/cell.2024.0026","volume":"26","author":"M Kaviani","year":"2024","unstructured":"Kaviani, M., Soleimanian, S., Keshtkar, S., Azarpira, N., Asvar, Z., & Pakbaz, S. (2024). Molecular prospective on malignant transformation of mesenchymal stem cells: An issue in cell therapy. Cellular Reprogramming, 26(3), 96\u2013106. https:\/\/doi.org\/10.1089\/cell.2024.0026","journal-title":"Cellular Reprogramming"},{"issue":"3","key":"11181_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11626-024-00852-z","volume":"60","author":"SP Chin","year":"2024","unstructured":"Chin, S. P., Saffery, N. S., Then, K. Y., & Cheong, S. K. (2024). Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells. In Vitro Cellular & Developmental Biology - Animal, 60(3), 307\u2013319. https:\/\/doi.org\/10.1007\/s11626-024-00852-z","journal-title":"In Vitro Cellular & Developmental Biology - Animal"},{"key":"11181_CR65","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.toxrep.2021.11.016","volume":"8","author":"C Th\u00e4te","year":"2021","unstructured":"Th\u00e4te, C., Woischwill, C., Brandenburg, G., M\u00fcller, M., B\u00f6hm, S., & Baumgart, J. (2021). Non-clinical assessment of safety, biodistribution and tumorigenicity of human mesenchymal stromal cells. Toxicology Reports, 8, 1960\u20131969. https:\/\/doi.org\/10.1016\/j.toxrep.2021.11.016","journal-title":"Toxicology Reports"},{"issue":"8","key":"11181_CR66","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jcyt.2025.04.069","volume":"27","author":"L Oppizzi","year":"2025","unstructured":"Oppizzi, L., Hosszu, K., Prockop, S., Bidgoli, A., Bonfim, C., Ciccocioppo, R., & Boelens, J. J. (2025). Immune monitoring after cell therapy and hematopoietic cell transplantation: Guidelines by the ISCT stem cell engineering committee. Cytotherapy, 27(8), 888\u2013902. https:\/\/doi.org\/10.1016\/j.jcyt.2025.04.069","journal-title":"Cytotherapy"},{"key":"11181_CR67","doi-asserted-by":"publisher","unstructured":"Silva, B., & Bragan\u00e7a, J. (2025). Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: Challenges and opportunities. World Journal of Stem Cells, 17(2). https:\/\/doi.org\/10.4252\/wjsc.v17.i2.99331","DOI":"10.4252\/wjsc.v17.i2.99331"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11181-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-026-11181-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-026-11181-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:59:00Z","timestamp":1788764340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-026-11181-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11181"],"URL":"https:\/\/doi.org\/10.1007\/s12015-026-11181-x","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"During the preparation of this work, the authors used AI-assisted tools strictly for English language polishing and grammatical correction to improve readability. After using this service, the authors thoroughly reviewed and edited the content as needed and take full responsibility for the scientific content and integrity of the publication.","order":1,"name":"Ethics","label":"Declaration of Generative AI and AI-assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}